IM Cannabis announces $1.6 million private placement to repay loan
Medical marijuana company IM Cannabis Corp. is planning a non-brokered private placement offering of up to $1.6 million through the sale of about 625,000 units.
14 licenses for cannabis social clubs granted in 4 German federal states
The number of applications and licenses granted for cannabis cultivation social clubs in Germany continued to grow throughout September, but growth has slowed month-over-month.
Second phase of German adult-use marijuana market launch in jeopardy
Germany’s long-anticipated “Pillar 2,” which would launch adult-use marijuana sales as part of a limited-duration pilot project, is in danger of being abandoned, according to elected officials.
Flora Growth inks deal to supply medical marijuana to German market
Cannabis operator Flora Growth Corp. announced an agreement with London-based Blossom Genetics to supply medical marijuana to the German market.
US cannabis brands embrace international expansion opportunities
Increased consumer demand for American cannabis products and emerging opportunities in Europe are driving some U.S. brands to expand internationally.
Cannabis producer Organigram closes on second tranche, reaps CA$41.5 million
A British American Tobacco subsidiary acquired roughly 4.4 million Organigram common shares and 8.5 million Class A preferred shares for gross proceeds of CA$41.5 million.
Is the future of cannabis in Europe? Q&A with Bloomwell CEO Niklas Kouparanis
Germany’s recreational cannabis market has limited opportunity, but Bloomwell Group’s Niklas Kouparanis is bullish on the medical market.
